The president, ceo and accomplished organic chemist (just look at uspto.gov for all of his discoveries) had the following words: "Indeed, encouraging medical innovation needs to be a key purpose of health care reforms in both the United States and the United Kingdom," Lechleiter said. "We must continually make the case for innovation through our words, but more importantly, through our actions and the value we bring to patients through innovative medicines."
Long story short: The federal government needs to spend billions to fund research like they did just prior to Lilly's "discovery" of SSRIs (which was based on US-funded, Noble laureate research). YOUR TAX DOLLARS AT WORK to fund the inadequacies of Lilly execs.